Literature DB >> 2807976

[Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center].

J Lerut, A C Stieber, L Makowka, C O Esquivel, S Iwatsuki, R D Gordon, T E Starzl.   

Abstract

During the cyclosporine era 1980-1984, 393 consecutive orthotopic liver transplantations (OLT) were performed in 313 patients at the University of Pittsburgh. This paper analyses the long-term results in this group of patients who have been followed-up for a minimum of three years. The results of OLT for different indications are discussed. The five-year survival rates after OLT for metabolic diseases, biliary atresia, primary biliary cirrhosis, posthepatic cirrhosis and primary hepatobiliary cancer are 75%, 68%, 60%, 58.9%, 53.2% and 23.8%, respectively. Recurrence of the primary disease after OLT is rare for benign diseases but rather frequent for malignant ones. The incidence of retransplantation for delayed rejection and for extrahepatic complications is discussed. The quality of life for most of the long-term survivors is good. Because of its good long-term results, OLT should become the therapy of choice in a lot of acute and chronic hepatopathies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807976      PMCID: PMC3007095     

Source DB:  PubMed          Journal:  Helv Chir Acta        ISSN: 0018-0181


  16 in total

1.  Orthotopic liver transplantation for primary sclerosing cholangitis.

Authors:  J W Marsh; S Iwatsuki; L Makowka; C O Esquivel; R D Gordon; S Todo; A Tzakis; C Miller; D Van Thiel; T E Starzl
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?

Authors:  J Lerut; A J Demetris; A C Stieber; J W Marsh; R D Gordon; C O Esquivel; S Iwatsuki; T E Starzl
Journal:  Transpl Int       Date:  1988-10       Impact factor: 3.782

3.  Orthotopic liver transplantation for fulminant and subacute hepatic failure.

Authors:  A C Stieber; G Ambrosino; D Van Thiel; S Iwatsuki; T E Starzl
Journal:  Gastroenterol Clin North Am       Date:  1988-03       Impact factor: 3.806

4.  New approaches in the use of cyclosporine: with particular reference to the liver.

Authors:  T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts.

Authors:  J P Lerut; R D Gordon; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

6.  Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; C O Esquivel; A G Tzakis; L Makowka; J W Marsh; B Koneru; A Stieber
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

7.  Changes in life-style after liver transplantation.

Authors:  B J Zitelli; J W Miller; J C Gartner; J J Malatack; A H Urbach; S H Belle; L Williams; B Kirkpatrick; T E Starzl
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

8.  Transplantation for primary biliary cirrhosis.

Authors:  C O Esquivel; D H Van Thiel; A J Demetris; A Bernardos; S Iwatsuki; B Markus; R D Gordon; J W Marsh; L Makowka; A G Tzakis
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

9.  Is there a place for liver grafting for malignancy?

Authors:  R Pichlmayr
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

10.  Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.

Authors:  A J Demetris; S Lasky; D H Van Thiel; T E Starzl; A Dekker
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.